Funder
Loxo
Jacobio
Exelixis
GlaxoSmithKline
BioAtla
Xencor
Epizyme
Abbisko Therapeutics
Fujifilm
Synthorx
Turning Point Therapeutics
Daiichi-Sankyo
Roche
Genentech
Novartis
Bayer
NanoCarrier
Vegenics
Celgene
Northwest Biotherapeutics
Berg Health
Incyte
PharmaMar
Pfizer
MultiVir
Amgen
AbbVie
Alfasigma
Agensys
Boston Biomedical
Idera Pharmaceuticals
Inhibrx
Blueprint Medicines
Loxo Oncology
MedImmune
Altum, Dragonfly Therapeutics
Takeda
National Comprehensive Cancer Network
National Cancer Institute Cancer Therapy Evaluation Program
The University of Texas MD Anderson Cancer Center
Boston Pharmaceuticals
Medscape